POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the third quarter ended September 30, 2014.
Corporate Highlights
•POZEN reported net income of $6.8 million for the third quarter, including $2.8 million of other income, comprised primarily of value attributable to a warrant to purchase 500,000 shares of Pernix Therapeutics Holdings, Inc. (Pernix) common stock. The Company continues to manage expenses and expects to be profitable and cash flow positive for the year.
Help employers find you! Check out all the jobs and post your resume.
Corporate Highlights
•POZEN reported net income of $6.8 million for the third quarter, including $2.8 million of other income, comprised primarily of value attributable to a warrant to purchase 500,000 shares of Pernix Therapeutics Holdings, Inc. (Pernix) common stock. The Company continues to manage expenses and expects to be profitable and cash flow positive for the year.
Help employers find you! Check out all the jobs and post your resume.
